Good news for kidney transplant recipients: New treatment significantly improved graft function
A new experimental treatment to prevent rejection of a transplanted kidney showed encouraging results in a clinical trial: In a two-year follow-up, higher kidney function was recorded compared to standard treatment • The drug received…
Assessment
A new experimental treatment for kidney transplant recipients has shown better graft function over two years compared to standard care. The drug has already received accelerated development status in the United States, which signals regulatory confidence. The next phase is a larger trial. If results hold, this could shift the standard of care for thousands of transplant patients.